A similar increase in phosphorylated tau at the ER was also seen in brain samples from Alzheimer’s disease patients, suggesting a common mechanism that may contribute to neurodegeneration (Perreault et al., 2009). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.